VBI Vaccines Will be Presenting at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
VBI Vaccines Inc. (NASDAQ:VBIV) will be presenting at the annual BMO Capital Markets Prescriptions for Success Healthcare Conference this year. The conference will be held on Thursday, December 14, at 11:00 am EST in New ... [Read]
Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’
A report on Tuesday from Zacks Investment Research upgraded VBI Vaccines (NASDAQ:$VBIV), Inc from a ‘Sell’ to a ‘Hold’ rating. VBI Vaccines is a biotechnology company that specializes in developing vaccines and antigens for issues ... [Read]
Zacks Investment Research Upgrades VBI Vaccines’ Rating
In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]
VBI Vaccines Inc and Its Technical Indicators
VBI Vaccines Inc (NASDAQ:$VBIV) may have caught the attention of investors when the SuperTrend line crossed above the current stock price recently. This indicator may signal that the stock may soon enter ‘Buy’ territory. The ... [Read]
VBI Vaccines, Inc.: What Can We Learn From Indicators and Metrics?
VBI Vaccines (NASDAQ:$VBIV) is a healthcare company specializing in the biotechnology industry. They have seen relatively little movement over the past month. So what can the technical indicators tell us about this pharmaceutical company? Let’s ... [Read]
Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating
In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]
VBI Vaccines’ Rating Upgraded by Zacks Investment Research
VBI Vaccines Inc (NASDAQ:$VBIV) saw its stock rating with Zacks Investment Research rise from ‘Sell’ to ‘Hold’ in a research note from Tuesday. VBIV is a biopharmaceuticals company that develops new technology focused on expanding ... [Read]
Here is What You Need to Measure VBI Vaccines Inc.’s Momentum
As of morning trading, VBI Vaccines Inc. (NASDAQ:$VBIV) shares are revealing a strong upward momentum, with the Aroon indicator reading above 70. Many investors are intrigued. Let’s look at the different metrics of measurement used ... [Read]
President and CEO of VBI Vaccines Set to Present at Jefferies 2017 Global Healthcare Conference
VBI Vaccines Inc. (NASDAQ:$VBIV), a biopharmaceutical company headquartered in Cambridge, MA, announced today that VBI’s President and CEO, Jeff Baxter, will be presenting at the Jefferies 2017 Global Healthcare Conference on Friday, June 9, 2017 ... [Read]